Stifel Financial Portfolio holdings
AUM
$103B
1-Year Return
17.55%
This Quarter Return
+1.11%
1 Year Return
+17.55%
3 Year Return
+67.43%
5 Year Return
+118.9%
10 Year Return
+263.91%
AUM
$96B
AUM Growth
+$648M
(+0.68%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
3,523
New
154
Increased
1,696
Reduced
1,434
Closed
149
Top Buys
| 1 |
Marsh & McLennan
MMC
|
$400M |
| 2 |
O'Reilly Automotive
ORLY
|
$139M |
| 3 |
SPDR Portfolio Mortgage Backed Bond ETF
SPMB
|
$59M |
| 4 |
Genuine Parts
GPC
|
$52M |
| 5 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
$45.3M |
Top Sells
| 1 |
Nike
NKE
|
$185M |
| 2 |
Cummins
CMI
|
$133M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
$79.2M |
| 4 |
Walmart
WMT
|
$78.9M |
| 5 |
Henry Schein
HSIC
|
$76M |
Sector Composition
| 1 | Technology | 20.14% |
| 2 | Industrials | 9.95% |
| 3 | Financials | 9.37% |
| 4 | Healthcare | 8.44% |
| 5 | Consumer Staples | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
NovaGold Resources
NG
$2.75B
| $37K | ﹤0.01% |
11,107
+165
| +2% | +$549 |
|
3327
BRC Inc
BRCC
$178M
| $35.4K | ﹤0.01% |
11,170
-141,038
| -93% | -$447K |
|
|
CKPT
3328
DELISTED
Checkpoint Therapeutics
CKPT
| $32.5K | ﹤0.01% |
+10,149
| New | +$32.5K |
|
|
HPP
3329
Hudson Pacific Properties
HPP
$1.17B
| $32.1K | ﹤0.01% |
10,604
+592
| +6% | +$1.79K |
|
|
SVC
3330
Service Properties Trust
SVC
$472M
| $31.5K | ﹤0.01% |
12,400
-20,822
| -63% | -$52.9K |
|
3331
NanoViricides
NNVC
$23.3M
| $30.3K | ﹤0.01% |
21,200
| – | – |
|
|
NNDM
3332
Nano Dimension
NNDM
$293M
| $28.2K | ﹤0.01% |
11,354
-3,300
| -23% | -$8.18K |
|
3333
Assertio
ASRT
$76.2M
| $27.4K | ﹤0.01% |
+31,500
| New | +$27.4K |
|
3334
Sportsman's Warehouse
SPWH
$122M
| $26.7K | ﹤0.01% |
10,000
| – | – |
|
3335
Opendoor
OPEN
$5.22B
| $26.3K | ﹤0.01% |
16,421
-2,987
| -15% | -$4.78K |
|
3336
Opko Health
OPK
$1.08B
| $24.7K | ﹤0.01% |
16,783
+94
| +0.6% | +$138 |
|
|
CIF
3337
MFS Intermediate High Income Fund
CIF
$31.7M
| $23.4K | ﹤0.01% |
13,542
| – | – |
|
3338
Fate Therapeutics
FATE
$115M
| $23.4K | ﹤0.01% |
14,175
-9,921
| -41% | -$16.4K |
|
3339
fuboTV
FUBO
$1.39B
| $23.2K | ﹤0.01% |
+18,383
| New | +$23.2K |
|
3340
Clearside Biomedical
CLSD
$27.3M
| $22.7K | ﹤0.01% |
23,944
+1,000
| +4% | +$950 |
|
|
KG
3341
Kestrel Group, Ltd.
KG
$196M
| $22.6K | ﹤0.01% |
670
| – | – |
|
3342
Senseonics Holdings
SENS
$370M
| $21.6K | ﹤0.01% |
41,320
+187
| +0.5% | +$98 |
|
3343
Pixelworks
PXLW
$53.6M
| $20.8K | ﹤0.01% |
2,371
| – | – |
|
3344
Rani Therapeutics
RANI
$24.1M
| $20.1K | ﹤0.01% |
14,684
-255,084
| -95% | -$349K |
|
3345
Sana Biotechnology
SANA
$741M
| $16.9K | ﹤0.01% |
10,397
+132
| +1% | +$215 |
|
3346
Seres Therapeutics
MCRB
$203M
| $16.6K | ﹤0.01% |
1,000
| – | – |
|
|
VXRT
3347
DELISTED
Vaxart
VXRT
| $16.6K | ﹤0.01% |
25,090
-2,400
| -9% | -$1.59K |
|
3348
FibroGen
FGEN
$45.2M
| $14.3K | ﹤0.01% |
1,081
-800
| -43% | -$10.6K |
|
|
ADAP
3349
Adaptimmune Therapeutics
ADAP
$11.3M
| $14.3K | ﹤0.01% |
26,469
-1,150
| -4% | -$619 |
|
3350
Origin Materials
ORGN
$79M
| $13.9K | ﹤0.01% |
10,840
| – | – |
|